Cargando…

Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers

Patients with rare central nervous system (CNS) tumors typically have a poor prognosis and limited therapeutic options. Historically, these cancers have been difficult to study due to small number of patients. Recent technological advances have identified molecular drivers of some of these rare canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arakaki, Aleena K S, Szulzewsky, Frank, Gilbert, Mark R, Gujral, Taranjit S, Holland, Eric C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561121/ https://www.ncbi.nlm.nih.gov/pubmed/34725698 http://dx.doi.org/10.1093/neuonc/noab183

Ejemplares similares

Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice
por: Szulzewsky, Frank, et al.
Publicado: (2022)

Rare central nervous system tumors: the path to progress
por: Penas-Prado, Marta
Publicado: (2021)

Olverembatinib inhibits SARS‐CoV‐2‐Omicron variant‐mediated cytokine release in human peripheral blood mononuclear cells
por: Chan, Marina, et al.
Publicado: (2022)

TB-6 Experimental evaluation of the therapeutic potential of boron neutron capture therapy in primary central nervous system lymphoma
por: Yoshimura, Kohei, et al.
Publicado: (2021)

SS-5 Current management of primary central nervous system lymphoma
por: Mishima, Kazuhiko, et al.
Publicado: (2020)

CBMS-04 Novel xenograft model to clarify tumor progressive mechanism and therapeutic target in primary central nervous system lymphoma
por: Tateishi, Kensuke, et al.
Publicado: (2020)

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
por: Kobayashi, Keiichi, et al.
Publicado: (2020)

ML-23 The outcome of malignant lymphoma of the central nervous system in a single institution
por: Kuwahara, Kiyonori, et al.
Publicado: (2020)

Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release
por: Chan, Marina, et al.
Publicado: (2021)

Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapy
por: Kang, Yuqi, et al.
Publicado: (2022)

ML-01 Pathological characteristics of primary central nervous system lymphoma with atypical radiological finding
por: Inukai, Madoka, et al.
Publicado: (2020)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

SURG-10. The evolving role of neurosurgery for central nervous system metastases in the era of personalized medicine
por: Karschnia, Philipp, et al.
Publicado: (2021)

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

ML-18 Clinical diagnosis for suspected primary central nervous system lymphoma patients without histopathological confirmation
por: Osawa, Sho, et al.
Publicado: (2020)

OTHR-04. Gynecological Malignancies With Metastasis To The Central Nervous System: A Case Series and Systematic Review of the Literature
por: Sajjad, Azeem, et al.
Publicado: (2021)

ML-13 Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab
por: Ohno, Masasuke, et al.
Publicado: (2021)

Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors
por: Armstrong, Terri S, et al.
Publicado: (2021)

Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis
por: Szulzewsky, Frank, et al.
Publicado: (2020)

Microbiology and Preclinical Review of Omadacycline
por: Karlowsky, James A, et al.
Publicado: (2019)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

ML-04 The influence of surgical intervention for high-dose Methotrexate chemotherapy in the patients with primary central nervous system lymphoma
por: Okamoto, Michinari, et al.
Publicado: (2020)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

KInhibition: A Kinase Inhibitor Selection Portal
por: Bello, Thomas, et al.
Publicado: (2018)

Non-linear Deep Neural Network for Rapid and Accurate Prediction of Phenotypic Responses to Kinase Inhibitors
por: Vijay, Siddharth, et al.
Publicado: (2020)

COT-04 Circulating biomarker for glioblastoma and primary central nervous system lymphoma -Next Generation Sequencing of small noncoding RNA-
por: Onishi, Shumpei, et al.
Publicado: (2020)

LMD-14. Preclinical safety and activity of intraventricular Rhenium-186 Nanoliposome ((186)RNL) for leptomeningeal metastases
por: Guerra-Garcia, Maria, et al.
Publicado: (2021)

Targeted, Evidence-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Benson, Al, et al.
Publicado: (2007)

Anticipating the Future: How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004)

A System-Wide Investigation of the Dynamics of Wnt Signaling Reveals Novel Phases of Transcriptional Regulation
por: Gujral, Taranjit S., et al.
Publicado: (2010)

Emerging approaches to study cell–cell interactions in tumor microenvironment
por: Nishida-Aoki, Nao, et al.
Publicado: (2019)

Moving Toward Disentangling Heterogeneity in Central Nervous System Complications in People With Human Immunodeficiency Virus
por: Rubin, Leah H, et al.
Publicado: (2023)

Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology
por: Joseph, Sarah B, et al.
Publicado: (2023)

Rare Primary Central Nervous System Tumors
por: Kubicky, Charlotte Dai, et al.
Publicado: (2014)

ML-3 A Case of Primary Central Nervous System Anaplastic Lymphoma Kinase Positive Anaplastic Large cell Lymphoma at Neurohypophysis and Pineal Gland
por: Kohno, Shohei, et al.
Publicado: (2021)

ECG Dispersion Mapping in Preclinical Diagnosis of Cardiovascular Diseases
por: Esina, E.Yu., et al.
Publicado: (2020)

Utility and delivery of behavioural interventions to prevent sexually transmitted infections
por: Aral, Sevgi O
Publicado: (2011)

ML-05 One-year follow-up data of phase I/II study of tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma
por: Mishima, Kazuhiko, et al.
Publicado: (2020)

Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
por: Ruderman, Eric M., et al.
Publicado: (2012)

Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors
por: Xue, Caroline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cvkfu9hb8nv591b88joi0l5e9b